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LETTERS TO THE EDITORRegarding “Reduced recanalization rates of the great
saphenous vein after endovenous laser treatment with
increase energy dosing: Definition of a threshold for
the endovenous fluence equivalent”
Regarding the article by Proebstle et al,1 several points should
be made to clarify the results and assumptions they make.
First, linear endovenous energy density (LEED) in Joules per
centimeter is an effective method to compare results only when the
mode of energy delivery and similar wavelengths are discussed. A
continuous pullback technique is not equivalent to the pulsed
pullback technique (equal amounts of thermal relaxation time
between energy delivery). From our published, and as of yet
ongoing histologic studies,2 all veins we studied perforated in the
810-nm, 940-nm, and 980-nmwavelengths when an equivalent of
80 J/cm was delivered in the continuous pullback mode. This
equivalent energy in the pulsed mode did not perforate the vein.
The reason this occurs is because in the continuous mode, heat
energy accumulates owing to the absence of a thermal relaxation
time. The cumulative energy is much higher than what would be
found with the pulsed pullback method. In this study, how was the
pullback rate measured accurately?
Because the effective energy at 15 watts is a median of 23.5
J/cm, we would expect much less perforation of the vein based on
our histologic studies with such a low equivalent of energy. Since
the percentage of patients with ecchymosis was similar in both
groups, regardless of intensity of energy, I would like to ask the
authors about the role of heparin in their patients. This may be one
of the reasons they have such a high rate of ecchymosis. Heparin
usage is not a usual and standard form of treatment after en-
dovenous ablation.
A point in comparing results that the authors make is the
endovenous fluence equivalent. It is a theoretical postulate that is
not consistent with what actually occurs at the time of the proce-
dure. There is no accurate determination to measure actual vein
size after the catheter, laser filament and tumescent solution has
been placed. Hence although not perfect, LEED remains our
choice when comparing energy.
Finally a factor to consider on examining the effectiveness of
laser energy at different levels or comparing different laser wave-
lengths, are the principal and secondary targets. Although the
mechanism of damage is water vaporization (steam bubble forma-
tion as first described by Proebstle et al)3 the 940-nm wavelength
also targets the heme proteins; hence, more energy would be
required to effect damage.
Even with the group receiving 15 watts, the authors were able
to obtain80% 1-year occlusion rates; even with 8% of the patients
lost to follow-up. The 1-year obliteration rate with the 30-watt
group was 97%, which compares with our reported results and
others. Based on our histologic studies of 1, 4, and 6 months, all
treated veins showed evidence of some micro-recanalization. This
is a normal phenomenon as a clot reorganizes from its initial
formation; however, unless persistent flow continues, for example,
a large incompetent perforator or branch, this is of no clinical
significance.
I would like to congratulate Dr Proebstle and his group on
their work with laser energies as pertains to endovenous abla-
tion.
Ronald G. Bush, MD, FACS
Midwest Vein Treatment Center
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Reply
We are grateful for the letter of Dr Bush because it adds
substantially to the discussion of energy dosing and successful
thermal endovenous vein ablation.
Unfortunately, we had to observe vein wall perforations with
any level of laser power, regardless of whether continuous or
pulsed fiber pullback was used. This was shown already in our very
first paper with pulsed laser firing at 15 watts.1 In our opinion,
perforation of the vein walls is unavoidable when using diode lasers
with dominant absorption by hemoglobin. Compared with radio-
frequency closure, this is a flaw of laser treatment itself and ac-
counts for the more pronounced side effects after laser compared
with radiofrequency.
Apart from the fact that without any damage of the vein wall
laser treatment was ineffective, dosing of laser energy turned out
to be the critical issue for successful vein ablation.2 Initially, we
also used the linear endovenous energy density (LEED) in
Joules per centimeter of treated vein to describe the delivered
laser energy. However, only the endovenous fluence equivalent
(EFE) took into account energy dosing for variable vein diam-
eters. For reasons of simplification, we calculated the EFE based
on cylindrical approximation of the inner vein surface using the
largest vein diameter in a supine patient. Therefore, the calcu-
lated value for EFE is a lower limit; in reality, values for EFE are
surely higher in parts of the treated vein that have smaller
diameters. Now, in the article of discussion where EFE was used
prospectively for the purpose of energy dosing, we were able to
recommend different values of LEED for different vein diameters.3
The argument that the supine diameter of the vein should
have nothing to do with the diameter of the compressed vein
after infiltration of tumescent local anesthesia was frequently
heard during discussions at numerous scientific meetings, and
looks reasonable at first sight. However, the simplicity of the
model takes this fact already into account. Regardless how
compressed the vein may be during laser firing, the vein wall
itself, including its inner surface, cannot vanish. They are still
the same matter as before when filled with blood, but the vein
wall is just in a different shape, it is kind of folded around the
laser fiber.
An interesting issue brought up in their letter is the role of
microvascularization of the endovenous clot in the ablated
veins. The understanding of this process and the definition of its
clinical significance could provide deep insight in the mecha-
nisms of neovascularization in general. However, this mecha-
nism is largely unclear at the moment. We therefore thank Dr
Bush for the interesting discussion points brought up in his
letter to the editor.
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